• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALI FEMORAL SYSTEM; VENA CAVA FILTER Back to Search Results
Model Number DL900F
Device Problems Detachment of Device or Device Component (2907); Patient Device Interaction Problem (4001)
Patient Problem Pulmonary Embolism (1498)
Event Date 11/27/2016
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a lot history review was performed.This is the only complaint to date for this lot number.Therefore, a device history record review is not required.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately five months later, the patient presented to the hospital with chest pain, a computed tomography angio (cta) chest with contrast was performed and it revealed small non-occlusive pulmonary embolism with a sub segmental branch involving the posterior basal segment of the left lower lobe.Embolized fractured inferior vena cava filter strut within a segmental branch to the anterior basal segment of the right lower lobe.An x-ray abdomen one view was performed, and it revealed there was missing one leg without the claw.Thus, the radiopaque density seen in the right chest likely is a leg of the inferior vena cava filter.An x-ray chest 1 view was performed, and it revealed linear metallic densities are seen over the right lower lobe.Therefore, the investigation is confirmed for alleged filter detachment.However, the investigation is inconclusive for the perforation of the ivc.Additionally, it can be confirmed that the patient experienced pe post-deployment.However, the relationship to the filter is unknown.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the filter struts detached, perforated into the organs.The device has not been removed and there were no reported attempts made to retrieve the filter.It was further reported that the detached strut retained in right lower lung.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALI FEMORAL SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key10182798
MDR Text Key196046893
Report Number2020394-2020-04024
Device Sequence Number1
Product Code DTK
UDI-Device Identifier00801741040801
UDI-Public(01)00801741040801
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2019
Device Model NumberDL900F
Device Catalogue NumberDL900F
Device Lot NumberGFAR4010
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/02/2020
Initial Date FDA Received06/23/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
COREG, FLEXERIL, FLOMAX, LASIX AND NOVOLOG MIX
Patient Outcome(s) Life Threatening;
Patient Age44 YR
-
-